Review article · 2016 · Open access
Treatment of negative symptoms: Where do we stand, and where do we go?
Schizophrenia Research, 186, 55–62 · Published 12 June 2016 · DOI 10.1016/j.schres.2016.05.015
In brief
“Treatment of negative symptoms: Where do we stand, and where do we go?” is a 2016 review article by André Aleman and 6 co-authors, published in Schizophrenia Research. OpenAlex counts 216 citations as of 20 November 2026. It is open access: the full text is free to read at University of Groningen research database (University of Groningen / Centre for Information Technology).
- Citations
- 216
- Most cited in
- 2022 (34)
- Field-weighted impact
- 2.25
- References
- 107
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Aleman, A., Lincoln, T. M., Bruggeman, R., Melle, I. S., Arends, J., Arango, C., & Knegtering, H. (2016). Treatment of negative symptoms: Where do we stand, and where do we go? Schizophrenia Research, 186, 55–62. https://doi.org/10.1016/j.schres.2016.05.015
MLA 9
Aleman, André, et al. “Treatment of negative symptoms: Where do we stand, and where do we go?” Schizophrenia Research, vol. 186, 2016, pp. 55–62. https://doi.org/10.1016/j.schres.2016.05.015.
Chicago
Aleman, André, Tania M. Lincoln, Richard Bruggeman, Ingrid S. Melle, Johan Arends, Celso Arango, and Henderikus Knegtering. 2016. “Treatment of negative symptoms: Where do we stand, and where do we go?” Schizophrenia Research 186: 55–62. https://doi.org/10.1016/j.schres.2016.05.015.
Harvard
Aleman, A. et al. (2016) ‘Treatment of negative symptoms: Where do we stand, and where do we go?’, Schizophrenia Research, 186, pp. 55–62. doi:10.1016/j.schres.2016.05.015.
IEEE
A. Aleman et al., “Treatment of negative symptoms: Where do we stand, and where do we go?,” Schizophrenia Research, vol. 186, pp. 55–62, 2016, doi: 10.1016/j.schres.2016.05.015.
BibTeX
@article{aleman2016treatment,
title = {{Treatment of negative symptoms: Where do we stand, and where do we go?}},
author = {Aleman, André and Lincoln, Tania M. and Bruggeman, Richard and Melle, Ingrid S. and Arends, Johan and Arango, Celso and Knegtering, Henderikus},
journal = {Schizophrenia Research},
year = {2016},
volume = {186},
pages = {55--62},
doi = {10.1016/j.schres.2016.05.015},
url = {https://doi.org/10.1016/j.schres.2016.05.015}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 19 | |
| 2018 | 19 | |
| 2019 | 20 | |
| 2020 | 24 | |
| 2021 | 26 | |
| 2022 | 34 | |
| 2023 | 21 | |
| 2024 | 16 | |
| 2025 | 12 | |
| 2026 | 19 |
Its field-weighted citation impact is 2.25: it has been cited 2.25 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- negative symptoms
- schizophrenia
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Aleman, A., Lincoln, T. M., Bruggeman, R., Melle, I. S., Arends, J., Arango, C., & Knegtering, H. (2016). Treatment of negative symptoms: Where do we stand, and where do we go? Schizophrenia Research, 186, 55–62. https://doi.org/10.1016/j.schres.2016.05.015
How many times has this paper been cited?
216 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at University of Groningen research database (University of Groningen / Centre for Information Technology): sign in and open the full text from this page.
Who wrote this paper?
André Aleman, Tania M. Lincoln, Richard Bruggeman, Ingrid S. Melle, Johan Arends, Celso Arango, Henderikus Knegtering.
What is the DOI of this paper?
10.1016/j.schres.2016.05.015, permanently at https://doi.org/10.1016/j.schres.2016.05.015. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.